Study of Pazopanib and Vorinostat in Patients With Advanced Malignancies

NCT01339871 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

152

Enrollment

OTHER

Sponsor class

Conditions

Advanced Cancer

Interventions

DRUG: Pazopanib
DRUG: Vorinostat

Sponsor

M.D. Anderson Cancer Center